Insightful, customized solutions for innovative business leaders
In today’s fast-paced marketplace and complicated regulatory environment, operating in the life sciences industry can bring a variety of challenges. From raising and managing capital to protecting intellectual property and prioritizing research and development efforts, you require business advisors who understand your complex issues and the speciﬁc business problems you might face.
Join RSM at CBI's 14th Life Sciences Accounting & Reporting Congress on March 19-21, 2018 in Philadelphia, PA.
Tax highlights for life sciences companies as you prepare for year-end filing and a look ahead to prepare for 2018.
Learn about key areas life sciences companies should address and steps they should take to implement the new revenue recognition guidance.
Third parties provide a vital business partnership for growing life sciences companies, but there are risks to consider.
This recent interview with Risk & Compliance magazine discusses the unique bribery and corruption risks life sciences organizations face.
A recent opinion by the Advocate General (AG) for the European Court of Justice (ECJ) opens the door for pharmaceutical companies to potentially claw back previously charged value added tax (VAT).
Life Sciences Insights
Contact Our Team
EVENTS / WEBCASTS
ON DEMAND WEBCAST
Join RSM on Dec. 13 as we share our insights on how the new revenue recognition standard (ASC 606) affects the life sciences industry.
RSM and McGuire Woods present the 15th annual health care and life sciences private equity conference for deal professionals.
Strategies for effectively working with third-parties (Webcast, March 29, 2018)